RecruitingNCT06219798

Evaluation of a Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease

Evaluation of a Multidisciplinary Care Pathway on the Evolution of Renal Function in Patients With Advanced Chronic Kidney Disease


Sponsor

Association d' Utilisation du Rein Artificiel SANTE

Enrollment

300 participants

Start Date

Apr 9, 2024

Study Type

OBSERVATIONAL

Conditions

Summary

The number of incident and prevalent patients with end stage renal disease on dialysis treatment is increasing in France and worldwide. A quarter of dialysis patients are initiating dialysis urgently through central venous catheters and the number of patients registered in the waiting list for renal transplantation before dialysis initiation is very low. This is also reflected in the very low number of pre-emptive renal transplantations. In order to reduce the number of dialysis patients, the French state has induced a national program proposing a multidisciplinary care pathway including the nephrology visits and at least one consultation with a dietitian and a specialist renal nurse in all patients with Chronic Kidney Disease stage 4 and 5. The aim of this single-center retrospective study is to evaluate the influence of the complete, partial or no participation in this program on the evolution of renal function and clinicobiological parameters in this group of patients.


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This observational study is reviewing medical records from patients with advanced chronic kidney disease (stage 4 or 5) who were enrolled in a specialized kidney care program, to evaluate how their kidney function changed over a 24-month period. This is a retrospective review — it uses existing data rather than enrolling new patients for treatment. **You may be eligible if...** - You were a patient with stage 4 or 5 chronic kidney disease enrolled in the AURA SANTE program between January 1 and December 31, 2021 - Your medical records contain sufficient data for a 24-month follow-up **You may NOT be eligible if...** - You had no medical follow-up during 2021 - Your records are incomplete or insufficient for the follow-up period - You were on corticosteroids, immunosuppressants, or cytotoxic drugs, or had an active infection, autoimmune disease, or active cancer during that period Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIAGNOSTIC_TESTGFR

Exit of the study due to death, dialysis, or transplantation


Locations(1)

Aura Sante

Chamalières, Auvergne, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06219798